Pandemic Response Lab (PRL) discovers first variant of COVID-19 from South Africa in citizens of New York
BROOKLYN, NY, February 21, 2021 / PRNewswire / – The Pandemic Response Lab (PRL) in new York, a world-class diagnostic life sciences company founded by Opentrons Labworks Inc., announced today that its scientists have discovered the first case of B1.351, the South African variant of COVID-19, in a New York State Residents.
At least 10 other cases of South African variants have been identified in the United States.
The New York City-based PRL that has been running high volume testing in this state since then September 2020started genome sequencing three weeks ago to track COVID-19 variants. When this new variant was discovered in a new York Residents, PRL notify federal, state, and local health authorities.
“The Pandemic Response Lab not only tests for COVID-19 quickly, efficiently and inexpensively. Our ability to track worrying variants is a key advantage in the fight against the virus. We are proud and honored to be part of this fight and we are excited on bringing our innovations to all fifty states, “said Jonathan Brennan-Badal, CEO of Opentrons.
- Using the technologies developed by Opentrons, PRL delivers high-precision PCR test results and next-generation viral genome sequencing at low cost. PRL delivers 99% of PCR results in 24 hours or less and costs 50% less than the national average for testing.
- PRL is expanding its sequencing capacity and is on track to meet public health sequencing requirements.
- PRL was selected by last September New York City manage its COVID-19 testing process. PRL also offers testing services to other customers, including hospital systems and large employers.
- Opentrons specializes in the manufacture of innovative automation solutions for robotics in healthcare. Its products are used in more than 2,000 laboratories in more than 40 countries.
Contact: Steve Posner, [email protected]202-841-1926
SOURCE The Pandemic Response Lab